Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease.

Mapuskar KA, Wen H, Holanda DG, Rastogi P, Steinbach E, Han R, Coleman MC, Attanasio M, Riley DP, Spitz DR, Allen BG, Zepeda-Orozco D.

Redox Biol. 2019 Jan;20:98-106. doi: 10.1016/j.redox.2018.09.020. Epub 2018 Sep 27.

2.

Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H₂O₂-Dependent Manner.

Heer CD, Davis AB, Riffe DB, Wagner BA, Falls KC, Allen BG, Buettner GR, Beardsley RA, Riley DP, Spitz DR.

Antioxidants (Basel). 2018 Jan 19;7(1). pii: E18. doi: 10.3390/antiox7010018.

3.

O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Kauffman EPS, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG.

Cancer Cell. 2017 Aug 14;32(2):268. doi: 10.1016/j.ccell.2017.07.008. No abstract available.

4.

Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy.

Mapuskar KA, Flippo KH, Schoenfeld JD, Riley DP, Strack S, Hejleh TA, Furqan M, Monga V, Domann FE, Buatti JM, Goswami PC, Spitz DR, Allen BG.

Cancer Res. 2017 Sep 15;77(18):5054-5067. doi: 10.1158/0008-5472.CAN-17-0106. Epub 2017 Aug 1.

5.

O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Shanahan Kauffman EP, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG.

Cancer Cell. 2017 Apr 10;31(4):487-500.e8. doi: 10.1016/j.ccell.2017.02.018. Epub 2017 Mar 30. Erratum in: Cancer Cell. 2017 Aug 14;32(2):268.

6.

Superoxide mediates acute liver injury in irradiated mice lacking sirtuin 3.

Coleman MC, Olivier AK, Jacobus JA, Mapuskar KA, Mao G, Martin SM, Riley DP, Gius D, Spitz DR.

Antioxid Redox Signal. 2014 Mar 20;20(9):1423-35. doi: 10.1089/ars.2012.5091. Epub 2013 Sep 28.

7.

Structure of kaolinite and influence of stacking faults: reconciling theory and experiment using inelastic neutron scattering analysis.

White CE, Kearley GJ, Provis JL, Riley DP.

J Chem Phys. 2013 May 21;138(19):194501. doi: 10.1063/1.4804306.

PMID:
23697422
8.

Likelihood of experiencing 'can't intubate, can't oxygenate'.

Riley DP.

Anaesth Intensive Care. 2012 Jul;40(4):722-3. No abstract available.

9.

A furnace and environmental cell for the in situ investigation of molten salt electrolysis using high-energy X-ray diffraction.

Styles MJ, Rowles MR, Madsen IC, McGregor K, Urban AJ, Snook GA, Scarlett NV, Riley DP.

J Synchrotron Radiat. 2012 Jan;19(Pt 1):39-47. doi: 10.1107/S0909049511039124. Epub 2011 Nov 15.

PMID:
22186642
10.

Shear stiffness in nanolaminar Ti3SiC2 challenges ab initio calculations.

Kisi EH, Zhang JF, Kirstein O, Riley DP, Styles MJ, Paradowska AM.

J Phys Condens Matter. 2010 Apr 28;22(16):162202. doi: 10.1088/0953-8984/22/16/162202. Epub 2010 Mar 30.

PMID:
21386405
11.

Characterization and dissolution of functionalized amorphous calcium phosphate biolayers using single-splat technology.

Gross KA, Young CJ, Beck MA, Keebaugh EW, Bronts TJ, Saber-Samandari S, Riley DP.

Acta Biomater. 2011 May;7(5):2270-5. doi: 10.1016/j.actbio.2011.01.020. Epub 2011 Feb 2.

PMID:
21295164
12.

Density functional modelling of silicate and aluminosilicate dimerisation solution chemistry.

White CE, Provis JL, Kearley GJ, Riley DP, van Deventer JS.

Dalton Trans. 2011 Feb 14;40(6):1348-55. doi: 10.1039/c0dt01042a. Epub 2010 Dec 22.

PMID:
21180742
13.

Density functional modeling of the local structure of kaolinite subjected to thermal dehydroxylation.

White CE, Provis JL, Proffen T, Riley DP, van Deventer JS.

J Phys Chem A. 2010 Apr 15;114(14):4988-96. doi: 10.1021/jp911108d.

PMID:
20297842
14.

Combining density functional theory (DFT) and pair distribution function (PDF) analysis to solve the structure of metastable materials: the case of metakaolin.

White CE, Provis JL, Proffen T, Riley DP, van Deventer JS.

Phys Chem Chem Phys. 2010 Apr 7;12(13):3239-45. doi: 10.1039/b922993k. Epub 2010 Feb 22.

PMID:
20237714
15.

What is the structure of kaolinite? Reconciling theory and experiment.

White CE, Provis JL, Riley DP, Kearley GJ, van Deventer JS.

J Phys Chem B. 2009 May 14;113(19):6756-65. doi: 10.1021/jp810448t.

PMID:
19388633
16.

Engineering metal complexes of chiral pentaazacrowns as privileged reverse-turn scaffolds.

Che Y, Brooks BR, Riley DP, Reaka AJ, Marshall GR.

Chem Biol Drug Des. 2007 Feb;69(2):99-110.

PMID:
17381723
17.

Therapeutic manipulations of peroxynitrite.

Salvemini D, Jensen MP, Riley DP, Misko TP.

Drug News Perspect. 1998 May;11(4):204-14.

PMID:
15616662
18.

On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, Salvemini D.

Br J Pharmacol. 2003 Oct;140(3):445-60. Review.

19.

Superoxide dismutase mimetics.

Salvemini D, Muscoli C, Riley DP, Cuzzocrea S.

Pulm Pharmacol Ther. 2002;15(5):439-47. Review.

PMID:
12406666
20.

Peroxynitrite decomposition activity of iron porphyrin complexes.

Jensen MP, Riley DP.

Inorg Chem. 2002 Sep 9;41(18):4788-97.

PMID:
12206706
21.

SOD mimetics are coming of age.

Salvemini D, Riley DP, Cuzzocrea S.

Nat Rev Drug Discov. 2002 May;1(5):367-74. Review.

PMID:
12120412
22.

The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages.

Mollace V, Salvemini D, Riley DP, Muscoli C, Iannone M, Granato T, Masuelli L, Modesti A, Rotiroti D, Nisticó R, Bertoli A, Perno CF, Aquaro S.

J Leukoc Biol. 2002 Jan;71(1):65-72.

PMID:
11781381
23.

Functional mimics of superoxide dismutase enzymes as therapeutic agents.

Riley DP.

Chem Rev. 1999 Sep 8;99(9):2573-88. No abstract available.

PMID:
11749493
25.

Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis.

Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Riley DP, Salvemini D.

Eur J Pharmacol. 2001 Nov 30;432(1):79-89.

PMID:
11734191
26.
27.

Computer-aided design (CAD) of Mn(II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme.

Aston K, Rath N, Naik A, Slomczynska U, Schall OF, Riley DP.

Inorg Chem. 2001 Apr 9;40(8):1779-89.

PMID:
11312732
28.

Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403.

Salvemini D, Mazzon E, Dugo L, Riley DP, Serraino I, Caputi AP, Cuzzocrea S.

Br J Pharmacol. 2001 Feb;132(4):815-27.

29.

Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.

Cuzzocrea S, Riley DP, Caputi AP, Salvemini D.

Pharmacol Rev. 2001 Mar;53(1):135-59. Review.

PMID:
11171943
30.

Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.

Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini D.

Br J Pharmacol. 2001 Jan;132(1):19-29.

31.

Nonpeptidyl mimetics of superoxide dismutase in clinical therapies for diseases.

Salvemini D, Riley DP.

Cell Mol Life Sci. 2000 Oct;57(11):1489-92. No abstract available.

PMID:
11092442
32.

Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock.

Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9753-8.

33.

A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats.

Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, Riley DP.

Science. 1999 Oct 8;286(5438):304-6.

34.

Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage.

Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TP.

Br J Pharmacol. 1999 Jun;127(3):685-92.

35.

Manganese-based superoxide dismutase mimetics inhibit neutrophil infiltration in vivo.

Weiss RH, Fretland DJ, Baron DA, Ryan US, Riley DP.

J Biol Chem. 1996 Oct 18;271(42):26149-56.

36.

Potentiation of nitric oxide-mediated vascular relaxation by SC52608, a superoxide dismutase mimic.

Kasten TP, Settle SL, Misko TP, Riley DP, Weiss RH, Currie MG, Nickols GA.

Proc Soc Exp Biol Med. 1995 Feb;208(2):170-7.

PMID:
7831349
37.

External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum haemorrhage.

Riley DP, Burgess RW.

Anaesth Intensive Care. 1994 Oct;22(5):571-5.

PMID:
7818062
38.

Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.

Black SC, Schasteen CS, Weiss RH, Riley DP, Driscoll EM, Lucchesi BR.

J Pharmacol Exp Ther. 1994 Sep;270(3):1208-15.

PMID:
7932173
39.

Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart.

Kilgore KS, Friedrichs GS, Johnson CR, Schasteen CS, Riley DP, Weiss RH, Ryan U, Lucchesi BR.

J Mol Cell Cardiol. 1994 Aug;26(8):995-1006.

40.

Superoxide dismutase mimetics inhibit neutrophil-mediated human aortic endothelial cell injury in vitro.

Hardy MM, Flickinger AG, Riley DP, Weiss RH, Ryan US.

J Biol Chem. 1994 Jul 15;269(28):18535-40.

41.

Evaluation of activity of putative superoxide dismutase mimics. Direct analysis by stopped-flow kinetics.

Weiss RH, Flickinger AG, Rivers WJ, Hardy MM, Aston KW, Ryan US, Riley DP.

J Biol Chem. 1993 Nov 5;268(31):23049-54.

42.

Novel instrumentation and biomedical applications of very near infrared fluorescence.

Brown MB, Edmonds TE, Miller JN, Riley DP, Seare NJ.

Analyst. 1993 Apr;118(4):407-10.

PMID:
8494173
43.

Transcutaneous cardiac pacing for asystole during permanent pacemaker lead repositioning.

Riley DP, Hales PA.

Anaesth Intensive Care. 1992 Nov;20(4):524-5. No abstract available.

PMID:
1463190
44.

Stopped-flow kinetic analysis for monitoring superoxide decay in aqueous systems.

Riley DP, Rivers WJ, Weiss RH.

Anal Biochem. 1991 Aug 1;196(2):344-9.

PMID:
1663709
45.
46.

Treatment of traumatically injured teeth.

Riley DP.

Bull San Diego Cty Dent Soc. 1973 Mar;43(1):10-3. No abstract available.

PMID:
4146057
47.

Oral implantology. Which direction to follow?

Riley DP.

Bull San Diego Cty Dent Soc. 1972 Dec;42(4):6-8. No abstract available.

PMID:
4510326
48.

Clinical pathological conference. Keratinizing folicular cyst.

Riley DP.

Bull San Diego Cty Dent Soc. 1972 Jun;42(2):4-6. No abstract available.

PMID:
4503345
49.

Clinical pathological conference: osteosarcoma.

Riley DP.

Bull San Diego Cty Dent Soc. 1972 Mar;42(1):12-3. No abstract available.

PMID:
4500742
50.

Clinical Pathological Conference.

Riley DP.

Bull San Diego Cty Dent Soc. 1971 Dec;41(8):12-4. No abstract available.

PMID:
5287151

Supplemental Content

Loading ...
Support Center